The Transcatheter Valve Replacement (TVR) market is a subset of the Cardiovascular Devices market. It is a minimally invasive procedure used to replace a diseased or damaged heart valve. The procedure involves inserting a catheter into the patient's body and guiding it to the heart, where the new valve is then deployed. The procedure is less invasive than traditional open-heart surgery, and is often used to treat patients who are at high risk for complications from open-heart surgery. TVR is a rapidly growing market, with new technologies and procedures being developed to improve patient outcomes. The market is expected to continue to grow as more patients are able to benefit from the procedure. Some of the companies in the TVR market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and St. Jude Medical. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
